Tuesday, December 5, 2023
Clinical Advances in the
Read Overview
Supported by an educational grant from AstraZeneca Pharmaceuticals.
Steering Committee Chair
General Practitioner, National Immunization Lead
Royal College of General Practitioners
President
British Global and Travel Health Association
London, United Kingdom
Head, Translational Pediatrics and Infectious Diseases Section
Pediatrics Department, Hospital Clinico Universitario de Santiago de Compostela
Coordinator of Genetics, Vaccines, Infections, and Pediatrics Research Group (GENVIP)
Healthcare Research Institute of Santiago de Compostela
Santiago de Compostela, Spain
Full Professor of Hygiene and Public Health
Director
Department of Health Sciences
University of Florence
Florence, Italy
Consultant Physician
Regional Infectious Diseases Unit
North Manchester General Hospital
Manchester, United Kingdom
Professor of Primary Care Research and Development
Usher Insitutute
College of Medicine and Veterinary Medicine
The University of Edinburgh
Edinburgh, United Kingdom
Professor of Medicine
University of Rochester School of Medicine
Rochester, New York
Steering Committee Chair
Has no relevant financial relationships.
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca Pharmaceuticals LP; Biofabri; GlaxoSmithKline; Janssen Biotech, Inc.; Merck Sharp & Dohme; Moderna, Inc.; Pfizer, Inc.; Sanofi; Shionogi & Co., Ltd.
Speaker or member of speakers bureau for: AstraZeneca Pharmaceuticals LP; GlaxoSmithKline; Merck Sharp & Dohme; Moderna, Inc.; Pfizer, Inc.; Sanofi
Research funding from: AstraZeneca Pharmaceuticals LP; Biofabri; GlaxoSmithKline; Merck Sharp & Dohme; Moderna, Inc.; Pfizer, Inc.; Sanofi
Other: I act as PI in research trials with honoraria paid to my institution for the following companies: AstraZeneca Pharmaceuticals LP; Biofabri; GlaxoSmithKline; Merck Sharp & Dohme; Moderna, Inc.; Pfizer, Inc.; Sanofi
Steering Committee Member
Has the following relevant financial relationships:
Speaker or member of speakers bureau for: AstraZeneca Pharmaceuticals LP; GlaxoSmithKline; Janssen Biotech, Inc. (former); Merck Sharp & Dohme; Moderna, Inc.; Novavax, Inc.; Pfizer, Inc.; Sanofi; Seqirus
Research funding from: Merck Sharp & Dohme; Sanofi
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: Gilead Sciences, Inc.; Generate; GlaxoSmithKline; Merck (Merck Sharpe & Dohme); ViiV Healthcare
Speaker or member of speakers bureau for: Gilead Sciences, Inc.; Merck (Merck Sharpe & Dome); ViiV Healthcare
Research funding from: Gilead Sciences, Inc.; Janssen Biotech, Inc.; ViiV Healthcare
Steering Committee Member
Has no relevant financial relationships.
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: ADMA Biologics; Arrow Pharmaceuticals; Gilead Sciences, Inc.; GlaxoSmithKline; Icosavax; Janssen Biotech, Inc.; Merck; Moderna, Inc.; Pfizer, Inc.; Sanofi Pasteur
Research funding from: CyanVac; Janssen Biotech, Inc.; Merck; Moderna, Inc.; Pfizer, Inc.; The Vaccine Company